secwatch / observer

Daily 8-K Digest — 2026-06-11

Generated June 11, 2026 at 8:31 PM ET · Covers June 11 trading day · 10 of 268 ready 8-Ks selected · AI-assisted overview

Several major corporate events were filed on June 11, 2026, led by two large M&A transactions: Eaton’s spin-off of its Mobility Group and combination with Dana in a $5.1B Reverse Morris Trust deal, and Chiesi’s completion of its $27/share acquisition of KalVista, which ceased trading on Nasdaq. Regulatory and compliance challenges dominated the day, including Coupang facing approximately $410M in Korean PIPC fines over data incidents, GoHealth receiving a Nasdaq delisting notice after its Chapter 11 filing (trading suspended June 16), and YHN Acquisition I receiving a deficiency notice for failing minimum holder requirements. Terra Property Trust extended its exchange offer for Senior Notes amid projected cash shortfalls, while Brady Corp announced a CEO transition from Russell Shaller to Vineet Nargolwala. Additionally, RegenerexPharma filed a lawsuit against its former CFO for alleged overpayments and overcharges, and OraSure received FDA clearance for its Colli-Pee Dx urine collection kit.
BRC BRADY CORP
leadership positive materiality 0.75 June 11, 2026, 3:01 PM ET

Brady CEO Russell Shaller retires; board member Vineet Nargolwala appointed CEO effective June 8, 2026

  • CEO Russell Shaller retires effective June 8, 2026; will serve as consultant through Aug 1, 2026 at current salary and benefits.
  • Vineet Nargolwala appointed President and CEO; annual base salary $1M, target bonus 125% of salary, annual equity award $6.4M.
  • Nargolwala receives matching RSU award up to $2M if he buys BRC stock within 180 days, vesting over two years.
CPNG Coupang, Inc.
regulatory negative materiality 0.85 June 11, 2026, 8:16 AM ET

Coupang faces ~$410M in Korean PIPC fines over data incident and ad program violations

  • Korean PIPC announced ~$278M fine for Nov 2025 data incident at Coupang Corp subsidiary.
  • Additional ~$132M fine for alleged violations in collection/storage of data from third-party ad program.
  • Fines and corrective actions subject to formal written decisions and judicial review; Coupang will appeal.
ETN Eaton Corp plc
M&A positive materiality 0.85 June 11, 2026, 6:40 AM ET

Eaton to spin off Mobility Group and merge with Dana in $5.1B Reverse Morris Trust deal

  • Eaton to separate Mobility Group and combine with Dana in Reverse Morris Trust transaction valued at ~$5.1B; combined company enterprise value >$10B.
  • Eaton to receive ~$1.1B cash distribution; Eaton shareholders to own at least 50.1% of combined company.
  • Combined company expected to generate ~$11B pro forma revenue and $1.7B pro forma adjusted EBITDA, with $250M run-rate cost synergies.
DAN DANA Inc
M&A positive materiality 1.00 June 11, 2026, 6:42 AM ET

Dana to combine with Eaton Mobility in $5.1B deal; combined revenue ~$11B

  • Transaction values Eaton Mobility at ~$5.1B (~8.3x 2026E adj. EBITDA before synergies); combined company enterprise value over $10B.
  • Reverse Morris Trust structure: Eaton shareholders own ≥50.1%, Dana shareholders ~49.9% post-close; Eaton receives ~$1.1B cash distribution.
  • Pro forma 2026 estimated sales ~$11B, adj. EBITDA ~$1.7B (~15% margin); $250M annual run-rate synergies within 24 months.
KALV KalVista Pharmaceuticals, Inc.
M&A neutral materiality 1.00 June 11, 2026, 4:44 PM ET

Chiesi completes $27/share acquisition of KalVista; shares cease trading on Nasdaq

  • Tender offer accepted 43,152,532 shares (~77.8% of outstanding) at $27.00 cash per share.
  • Back-end merger closed June 11, 2026; KalVista now wholly owned by Chiesi Group.
  • KalVista stock halted June 10 and delisted from Nasdaq Global Market effective June 11.
RGPX REGENEREX PHARMA, INC.
litigation negative materiality 0.75 June 11, 2026, 1:52 PM ET

Regenerex sues former CFO Perry for alleged $55K overpayments, $37K overcharges, stock theft

  • Complaint filed June 5, 2026, in Smith County Chancery Court (Case No. 2026-CV-8813).
  • Alleges former CFO Perry caused unauthorized payroll overpayments totaling ~$55,200 over six months.
  • Perry's company Optimize Health overbilled $136,056; includes alleged 30% administrative fee of ~$37,285.
TPTA Terra Property Trust, Inc.
debt negative materiality 0.85 June 11, 2026, 6:11 AM ET

Terra Property Trust extends exchange offer to June 25; projects cash inflows of $47.1M vs outflows up to $51.9M

  • Exchange offer for 6.00% Senior Notes due June 30, 2026 extended to June 25, 2026; new terms include 11.00% rate, first-lien collateral, shorter maturity.
  • Cash flow projections (Apr-Sep 2026): $47.1M inflows vs $51.9M outflows (65.7% participation) or $37.9M outflows (full participation).
  • June cash payments on Existing Notes: $27.7M (partial) or $13.6M (full); $13.3M secured borrowing repayment due Sept.
YHNA YHN Acquisition I Ltd
regulatory negative materiality 0.60 June 11, 2026, 12:28 PM ET

YHN Acquisition I receives Nasdaq deficiency notice for failing minimum total holders requirement

  • Received Nasdaq notice on June 10, 2026 for non-compliance with Listing Rule 5450(a)(2) requiring 400 total holders.
  • Has 45 calendar days to submit a plan to regain compliance; Nasdaq may grant up to 180-day extension.
  • Trading continues under symbols YHNAU, YHNA, YHNAR; company may consider transfer to Nasdaq Capital Market.
GOCO GoHealth, Inc.
other material negative materiality 1.00 June 11, 2026, 4:14 PM ET

GoHealth receives Nasdaq delisting notice after Chapter 11 filing; trading suspended June 16

  • Nasdaq delisting based on Chapter 11 filing, public interest concerns, and residual equity holder issues.
  • Trading of GOCO suspended at opening of business on June 16, 2026; Form 25-NSE to follow.
  • Company will not appeal the delisting determination.
OSUR ORASURE TECHNOLOGIES INC
regulatory positive materiality 0.55 June 11, 2026, 9:02 AM ET

OraSure receives FDA clearance for Colli-Pee Dx urine collection kit for STI tests on Roche systems

  • FDA clearance covers Colli-Pee Dx kit for use with Roche cobas 5800/6800/8800 systems for CT, NG, TV, MG pathogens.
  • Kit enables at-home self-collection of first-void urine for both male and female patients.
  • Subsidiary DNA Genotek's product expands OraSure's at-home diagnostics portfolio.
Generated from SEC 8-K filings received on 2026-06-11. Not investment advice. · Live feed · Executive changes · All-filings RSS · Methodology
Item-code hubs covered today: · 1.01 · 1.02 · 2.01 · 2.03 · 3.01 · 3.03 · 5.01 · 5.02 · 5.03 · 7.01 · 8.01 · 9.01